evaluation of the effect of levothyroxine on benign thyroid nodule volume

Phase 2

• Conditions: Thyroid nodule.; Disorders of thyroid gland; E00-E07

• Registration Number: IRCT2016092624021N2
• Lead Sponsor: Guilan University of Medical Sciences, Vice chancellor for research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

patiens with single or multi thyroid nodules that have been proved to be benign with FNA
Exclusion criteria:age under 20 and over 60; hypo or hyper thyroidism; history of using levothyroxine during past year; osteoporosis ; pregnancy; cardiovascular disease

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Thyroid nodule volume. Timepoint: beginning of assessment,6 months later after intervention , 12 months later ,18 months later , 24 months later. Method of measurement: ultrasound.

Secondary Outcome Measures

Name	Time	Method
TSH. Timepoint: before intervention, 6 weeks later, then every 3 months. Method of measurement: laboratory kit.